Nec - Case matches

Nec Lawsuit

NEC in Premature Infants?

Cow’s milk-based infant formulas and fortifiers have been associated with a higher risk of Necrotizing Enterocolitis (NEC), a serious and potentially fatal condition in premature babies. Despite these dangers, leading manufacturers like Abbott and Mead Johnson did not provide sufficient warnings. If your child developed NEC, you may have the right to seek compensation for their suffering or loss. Even if the incident happened years ago, you could still be eligible to file a claim.

NEC: A Serious and Life-Threatening Condition

Necrotizing Enterocolitis (NEC) is a critical gastrointestinal disease that mainly affects premature infants. It leads to inflammation and intestinal damage, which can cause tissue death or perforation. When this occurs, harmful bacteria may enter the abdomen, resulting in severe infections and complications.

Common NEC symptoms include abdominal swelling, bloody stools, feeding difficulties, lethargy, and unstable body temperature. In severe cases, NEC can lead to bowel perforation, sepsis, organ failure, or even death. Treatment typically involves stopping feedings, administering IV fluids and antibiotics, and, in some cases, surgery to remove damaged intestinal tissue.

The Hidden Risks of Infant Formula

Premature infants need specialized nutrition to support their growth and address their low birth weight. Brands like Similac and Enfamil market their formulas as complete substitutes for breast milk, designed to promote weight gain in newborns.

However, studies have linked these formulas to a higher risk of necrotizing enterocolitis (NEC) in premature babies. A 1990 study published in The Lancet revealed that formula-fed preemies were 10 times more likely to develop NEC. Despite several scientific findings pointing to these risks, manufacturers did not provide adequate warnings to parents.

NEC is a severe gastrointestinal condition that can lead to the death or perforation of intestinal tissue, resulting in infections, lifelong complications, or even death. Symptoms of NEC may include:

Loss of appetite
Diarrhea
Abdominal pain and swelling
Abnormal breathing
Changes in heart rate or blood pressure
Difficulty gaining weight

Contact Us Now.

Name

Phone

Message

Case

Consent

By clicking the ‘Submit’ button, I provide my electronic signature, agreeing to this website’s Privacy Policy, TCPA Consent & Privacy Disclaimer. I expressly consent to receiving calls, text messages, and emails from call centers, affiliates associated with ‘Case matches or automatic telephone dialing systems, even if my number is listed on the federal Do Not Contact list. I understand my consent is not a condition of purchasing any goods or services. My telephone company may impose charges for these contacts.

Claim Application Now

Johnson & Johnson has agreed to a $700 million settlement to resolve investigations from over 40 states concerning the marketing of talcum powder products. This settlement addresses state-level claims that the company concealed the cancer risks associated with its products, but it does not impact the more than 50,000 cases in the federal MDL.

Families who have lost a loved one to talcum powder-related cancer may also be eligible for compensation for loss of consortium, as wrongful death claims typically receive higher settlements. Compensation will depend on the specific details of each case and a settlement matrix.

If you’ve been diagnosed with ovarian cancer or mesothelioma after using talcum powder, consider applying for your claim today.

CONTACT US

Call us to get started or complete the form on this page. Our team will promptly reach out to walk you through the lawsuit process and assist in holding Roundup manufacturers accountable.

FREE CASE EVALUATION

Share your story with us, ask any questions you may have, and let us begin gathering the information needed to build a strong case on your behalf. No upfront fees are required.

SEEK JUSTICE

We’ll manage every step of your case, so you can focus on your health and family.